Ebba Sohlberg
DMPK, AstraZeneca R&D
Soedertaelje, AB 15185, Sweden
Soedertaelje, AB 15185, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025
The innate power of natural killer cells in cancer therapy.
Journal: Nature medicine
Published: May 12, 2025
A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansion.
Journal: PLoS pathogens
Published: October 31, 2024
A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansion.
Journal: bioRxiv : the preprint server for biology
Published: August 30, 2024
Interleukin-12 decorated nanosized semiflexible Immunofilaments enable directed targeting and augmented IFNγ responses of natural killer cells.
Journal: Acta biomaterialia
Published: August 13, 2024
Targeting HLA-E-overexpressing cancers with a NKG2A/C switch receptor.
Journal: Med (New York, N.Y.)
Published: January 30, 2024
Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping.
Journal: Nature immunology
Published: October 25, 2023
Clinical and immunological features in ACKR1/DARC-associated neutropenia.
Journal: Blood advances
Published: April 06, 2023
Functional SARS-CoV-2 cross-reactive CD4+ T cells established in early childhood decline with age.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 14, 2023
Effect of mTOR Inhibition with Sirolimus on Natural Killer Cell Reconstitution in Allogeneic Stem Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: January 22, 2023
Last Updated: 09/26/2026